• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1990 Fiscal Year Final Research Report Summary

AntiーCD3 Monoclonal Antibody and IL-2 Induced Cytotoxicity of T Lymphocytes from Oral Cancer Patients.

Research Project

Project/Area Number 01571088
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field 外科・放射線系歯学
Research InstitutionFaculty of Dentistry, Tokyo Medical and Dental University

Principal Investigator

TAKAHASHI Yuzo  Tokyo Medical and Dental University, Faculty of Dentistry, Research associate, 歯学部, 助手 (50014329)

Co-Investigator(Kenkyū-buntansha) KUSAMA Mikio  Tokyo Medical and Dental University, Faculty of Dentistry, Research associate, 歯学部, 助手 (60124690)
FUJIBAYASHI Takashi  Tokyo Medical and Dental University, Faculty of Dentistry, Assistant prof., 歯学部, 講師 (80013978)
Project Period (FY) 1989 – 1990
KeywordsOral cancer / Adoptive immunotherapy / Lymphkine-activated killer (LAK) / Interleukin-2(IL-2) / Anti-CD3 monoclonal antibody
Research Abstract

A Grest number of cells, which have high level of cytotoxic activity, are demanded for successful adoptive immunotherapy with Lymphokine-Activated Killer (LAK) cells. We attempted to make culture CD3-LAK cells using anti-CD3 monoclonal antibody and interleukin-2, and investigated how the proliferative response and cytotoxic activity of LAK cells (CD3・LAK) are affected by BRM (cytokines, OK432, etc.). In clinically, therapeutic effects of the combination of radiation therapy, chemotherapy and adoptive immunotherapy are expected, therefor, we investigated the effect of these therapy on CD3-LAK cells.
1. Induction of CD3・LAK cells : High proliferative response and cytotoxic activity were induced from peripheral blood lymphocytes (PBL) by using anti-CD3 monoclonal antibody and IL-2.
2. The effect of cytokines (rIFNgamma, rTNF alpha, rG-CSF, rIL-1 alpha, rIL-1beta) on CD3・LAKcells : Proliferative response of CD3・LAK cells increased by rTNFalpha at low concentration of rIL-2. Cytotoxic activity of these cells were not affected by any cytokines. At the first stage of CD・LAK induction, OK432 significantly enhanced cytotoxic activity of these cells.
3. The effect of antineoplastic agent (CDDP, 5-FU, MTX, PEP, BLM, ADR) and irradiation (1.25, 2.5, 5.0, 10.0, 20.0Gy) on CD3・LAK cells : Proliferative response of CD3-LAK cells were suppressed by both antineoplastic agent and irradiation.Cytotoxic activiy of these cells were neither affected by antineoplastic agent nor irradiation.
These results indicate that LAK induction using together anti-CD3 monoclonal antibody with rIL-2 is available for adoptive immunotherapy on oral cancer patients, and that therapeutic effects of adoptive immunotherapy in combination with chemotherapy and radiation therapy are expected.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] 高橋 雄三: "インターロイキン2活性化口腔癌患者未梢血リンパ球の自己新鮮腫瘍細胞に対する細胞障害活性" 日本口腔外科学会雑誌. 35. 341-360 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 高橋 雄三: "口腔癌の抗腫瘍性Cytokine療法" 口腔病学会雑誌. 56. 186 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 森 良之: "腫瘍組織浸潤リンパ球(TIL)からのrILー2による細胞障害活性の誘導" BIOTHERAPY. 3. 80-84 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 高橋 雄三: "口腔癌とBRM療法" 日本口腔外科学会雑誌. 35. 1690-1698 (1989)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 高橋 雄三: "口腔癌の養子免疫療法(ILー2培養自己リンパ球移入療法)" 口腔病学会雑誌. 57. 354 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 高橋 雄三: "LAK細胞の細胞障害活性(NKおよびLAK活性)ならびにILー2による細胞増殖に対する放射線照射の影響" 日本頭頸部腫瘍学会誌.

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 高橋 雄三: "日本口腔外科学会雑誌" 口腔癌患者における抗CD3抗体およびILー2活性化自己リンパ球(LAK細胞)の腫瘍集積性ならびに体内動態の観察,

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] TAKAHASHI, Yuzo: "Lysis of fresh autologous tumor cells by interleukin 2 activated peripheral blood lymphocytes in patients with oral cancer." Jpn. J. Oral. Maxillofac. Surg.Vol. 35 No. 2. 341-360 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] TAKAHASHI, Yuzo: "Cytokines in treatment for oral cancer." The Journal of Stomatological Society, Japan. Vol. 56 No. 1. 186 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] MORI, Yoshiyuki: "Recombinant interleukin 2 (rIL2) induced cytotoxicity of tumor infiltrating lymphocytes (TIL) in oral cancer patients." Biotherapy. Vol. 3 No. 1. 80-84 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] TAKAHASHI, Yuzo: "BRM in the treatment for oral cancer." Jpn. J. Oral. Maxillofac. Surg.Vol. 35 No. 6. 1690-1698 (1989)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] TAKAHASHI, Yuzo: "Adoptive immunotherapy for oral cancer (Adoptiveーimmunotherapy with IL-2 activated autologous lymphocytes)" The Journal of the Stomatological Society, Japan. Vol. 57 No. 2. 354 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] TAKAHASHI, Yuzo: "The effects of radiation on the cytotoxicity for NK and LAK activity and proliferative response to IL-2 of the lymphokine-activated killer (LAK) cells." J. Japan Society for Head and Neck Cancer.

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] TAKAHASHI, Yuzo: "In vivo distribution of adoptively transferred anti-CD3 monoclonal antibody and interleukin-2 activated autologous lymphocytes (LAK) in patients with oral cancer." Jpn. J. Oral. Maxillofac. Surg.

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1993-08-12  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi